Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 23 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2002International federation of clinical chemistry/international association of therapeutic drug monitoring and clinical toxicology working group on immunosuppressive drug monitoringHolt, D.; Armstrong, V.; Griesmacher, A.; Morris, R.; Napoli, K.; Shaw, L.
2001Population pharmacokinetics of perhexiline from very sparse, routine monitoring dataHussein, R.; Charles, B.; Morris, R.; Rasiah, R.
2001Population pharmacokinetics of lamotrigineChan, V.; Morris, R.; Ilet, K.; Tett, S.
2001Survey of intensive care units and availability of drug assays in AustralasiaMorris, R.; Kennedy, M.; Kiloh, N.
2005CEDIAƒ sirolimus assay compared with HPLC-MS/MS and HPLC-UV in transplant recipient specimensWestley, I.; Morris, R.; Taylor, P.; Salm, P.; James, M.
2004Long-term follow-up using a higher target range for lamotrigine monitoringMorris, R.; Lee, M.; Cleanthous, X.; Black, A.
2002Cyclosporin monitoring in Australasia: 2002 update of concensus guidelinesMorris, R.; Ilet, K.; Tett, S.; Ray, J.; Fullinfaw, R.; Cooke, R.; Cook, S.
2000Clinical study of lamotrigine and valproic acid in patients with epilepsy: Using a drug interaction to advantage?Morris, R.; Black, A.; Lam, E.; Westley, I.
2000Cyclosporin assays, metabolite cross-reactivity, and pharmacokinetic monitoringMorris, R.
2004Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexilineDavies, B.; Coller, J.; James, H.; Gillis, D.; Somogyi, A.; Horowitz, J.; Morris, R.; Sallustio, B.